ClinVar Miner

Submissions for variant NM_001110792.2(MECP2):c.191A>G (p.His64Arg)

dbSNP: rs61754433
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Rett and Angelman-like Disorders Variant Curation Expert Panel RCV002472326 SCV002769692 benign Rett syndrome 2022-10-11 reviewed by expert panel curation The allele frequency of the p.His52Arg variant in MECP2 (NM_004992.3) is 0.121% in the South Asian sub population in gnomAD, which is high enough to be classified as benign based on thresholds defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like conditions (BA1). In summary, the p.His52Arg variant in MECP2 is classified as Benign based on the ACMG/AMP criteria (BA1).
Labcorp Genetics (formerly Invitae), Labcorp RCV001520931 SCV001730147 benign Severe neonatal-onset encephalopathy with microcephaly 2024-01-18 criteria provided, single submitter clinical testing
GeneDx RCV001689675 SCV001915565 benign not provided 2020-02-17 criteria provided, single submitter clinical testing
Centre for Population Genomics, CPG RCV002472326 SCV004101592 benign Rett syndrome 2023-10-12 criteria provided, single submitter curation This variant has been collected from RettBASE and curated to current modified ACMG/AMP criteria. Based on the classification scheme defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders Specifications to the ACMG/AMP Variant Interpretation Guidelines VCEP 2.0, this variant is classified as benign. At least the following criteria are met: The allele frequency of this variant in at least one population in gnomAD is higher than the 0.03% threshold defined by the ClinGen Rett/Angelman-like Expert Panel for Rett/AS-like Disorders VCEP 2.0 (BA1).
Ambry Genetics RCV004639141 SCV005133820 likely benign Inborn genetic diseases 2024-06-16 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
RettBASE RCV000133025 SCV000188012 uncertain significance not specified 2006-02-03 no assertion criteria provided curation
PreventionGenetics, part of Exact Sciences RCV004734683 SCV005363453 likely benign MECP2-related disorder 2024-05-31 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.